Study of the Aortic and Large Arterial Vessel Infections
Condition(s) studied
Study summary
Aortic or large arterial vessel infections are rare but serious infections. Their management is based on French and American expert opinions. The quality of evidence supporting these guidelines is low because most publications on the subject correspond to case series and few interventional studies have been performed to validate their management. However, referral centres for vascular surgery are frequently solicited to give their opinion on patients suffering from mycotic aneurysms. In addition, the last few decades have seen the improvement of vascular surgery techniques allowing the management of more and more patients, often elderly and comorbid. There has therefore been an increase in the incidence of infectious complications associated with this care. It is therefore essential to participate in research on aortic and large arterial vessel infections. For this, a monocentric cohort study seems to be an essential first step to better understand the polymorphism and complexity of these patients.
Eligibility
Primary outcome measure(s)
- one-year mortality — one year after the diagnosis
Study of all-cause mortality in patients with aortic vascular infection and large arterial vessels during the first year of follow-up after diagnosis.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Université de Lorraine, CHRU Nancy and APEMAC | Vandœuvre-lès-Nancy | Lorraine | Recruiting |
More Central Hospital, Nancy, France trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05660733 on ClinicalTrials.gov ↗ ← All trials in France